Takeda Pharmaceutical Company

TAK

TOKYO STOCK EXCHANGE-TOKYO PRO MARKETHealth Care

Income Statement

Total Revenue$30.18B

Gross Profit$19.76B

Operating Income$2.71B

EBITDA$7.93B

EBIT$2.93B

Pre-tax Income$260.19B

Net Income$1.38B

Cash Equivalent$4.33B

Total Debt$38.69B

Book Value$47.96B

Book Value Per Share30.40

Return on Equity (ROE)+1.56%

Return on Assets (ROA)+76.00%

Return on Invested Capital (ROI)+94.00%

Net Profit Margin+2.36%

Current Ratio1.01

Quick Ratio0.52

Long-Term Debt / Equity0.57